FLEXIDO
DEAD

Serial Number

97194839

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FLEXIDO Trademark

Serial Number: 97194839

FLEXIDO is a trademark filed by Novartis AG on December 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Novartis AG

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

December 29, 2021

Registration Date

Not Registered

Published for Opposition

November 8, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2026 ABN6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2025 EXRA
SOU EXTENSION 5 GRANTED
Dec 11, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 11, 2025 AITU
SOU EXTENSION 5 FILED
Jun 30, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2024 EXRA
SOU EXTENSION 4 GRANTED
Dec 30, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 30, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jul 2, 2024 EX3G
SOU EXTENSION 3 FILED
Jul 2, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 30, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 28, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 28, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 1, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 29, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 29, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 29, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2022 CNSA
ASSIGNED TO EXAMINER
Oct 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2022 NWOS
NEW APPLICATION ENTERED
Jan 1, 2022 NWAP